Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Tax Provisions (2020 - 2024)

Vericel (VCEL) posted Tax Provisions of $148000.0 for Q4 2024, down 86.55% sequentially from $1.1 million in Q4 2023, and down 86.55% YoY from $1.1 million in Q1 2024.

Analysis

Vericel (VCEL) Tax Provisions (2020 - 2024) Analysis & Trends

Vericel has reported Tax Provisions for 5 years, with the latest figure at $148000.0 in Q4 2024.

  • Quarterly Tax Provisions fell 86.55% year-over-year to $148000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $962000.0 (down 37.33% YoY) and the FY2025 annual result came in at $859000.0, up 480.41% from the prior year.
  • Tax Provisions fell to $148000.0 in Q4 2024 per VCEL's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.1 million in Q4 2023 and troughed at -$326000.0 in Q4 2021.
  • A 5-year average of $194666.7 and a median of $143000.0 in 2021 frame the typical range for Tax Provisions.
  • The sharpest annual moves came in 2022 and 2023: Tax Provisions soared 314.72% in 2022, then slumped 1461.9% in 2023.
  • Over 5 years, Tax Provisions stood at $180000.0 in 2020, then slumped by 281.11% to -$326000.0 in 2021, then jumped by 314.72% to $700000.0 in 2022, then jumped by 57.14% to $1.1 million in 2023, then sank by 86.55% to $148000.0 in 2024.
  • According to Business Quant data, Tax Provisions over the past three periods registered $148000.0, $1.1 million, and -$286000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -59.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.90 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 148,000.00
Dec 31, 2023 1.10 Mn
Sep 30, 2023 -286,000.00
Dec 31, 2022 700,000.00
Sep 30, 2022 21,000.00
Dec 31, 2021 -326,000.00
Jun 30, 2021 72,000.00
Mar 31, 2021 143,000.00
Dec 31, 2020 180,000.00